Quifol 10 mg/ 20 ml Injection
PDF Leaflet Revision Date: 22-July-2025
Clinical Summary
Quick overview from the medicine insert
Indication
Induction and maintenance of general anaesthesia, sedation in ICU, and conscious sedation for procedures.
Dosage (summary)
Induction: 1.5-2.5 mg/kg; Maintenance: 4-12 mg/kg/hr; ICU sedation: 0.3-4 mg/kg/hr.
Onset of Action / Duration
Onset: 30 secs, Duration: varies with administration.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended in pregnancy; safety in breastfeeding not established.
Key Drug Interactions
- Narcotics
- Benzodiazepines
- Neuromuscular blockers
Contraindications
- Hypersensitivity to propofol
- Children under 3 years
- Fat metabolism disorders
Common side effects
- Hypotension
- Apnoea
- Nausea
- Vomiting
- Bradycardia
Counselling Points
- Monitor for respiratory depression
- Avoid driving post-anesthesia
- Report any adverse reactions
Serious warnings
- Respiratory depression
- Anaphylactic reactions
- Cardiac arrhythmias
Important Disclaimer
The Quifol 10 mg/ 20 ml Injection professional information leaflet below is the property of Qhayisa 2014 Trading And Projects Pty Ltd T/A and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
